Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-28

Clinical Trial Update: Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of AstroStem for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AstroStem

Snippet

Sponsor: Nature Cell Co. Ltd. | Conditions: Alzheimer Disease | Phase 2 | Status: UNKNOWN